MENVEO
Meningococcal Group A, C, W135 and Y Conjugate Vaccine Ph. Eur 0.5ML
MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals 2 months through 55 years of age. MENVEO does not prevent N. meningitidis serogroup B infections.